The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis

Purpose. Secondary hemophagocytic lymphohistiocytosis (sHLH) accompanied by liver involvement, characterized by hepatomegaly and increased liver enzymes, is usually associated with elevated mortality. However, the magnitude of these associations remains unknown. Our objective was to assess the assoc...

Full description

Saved in:
Bibliographic Details
Main Authors: Guangli Yin, Changfeng Man, Shengen Liao, Hongxia Qiu
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2020/5719751
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849467710100996096
author Guangli Yin
Changfeng Man
Shengen Liao
Hongxia Qiu
author_facet Guangli Yin
Changfeng Man
Shengen Liao
Hongxia Qiu
author_sort Guangli Yin
collection DOAJ
description Purpose. Secondary hemophagocytic lymphohistiocytosis (sHLH) accompanied by liver involvement, characterized by hepatomegaly and increased liver enzymes, is usually associated with elevated mortality. However, the magnitude of these associations remains unknown. Our objective was to assess the associations of the aspartate transaminase/alanine transaminase (AST/ALT, De Ritis) ratio with overall survival among adult patients with sHLH. Methods. A retrospective analysis was performed on 289 patients aged 18–86 years with complete serum transaminase data at diagnosis of sHLH. Multivariate Cox regression analyses and restricted cubic splines were conducted to address the association between the De Ritis ratio and the risk of mortality. Results. The median De Ritis ratio for the entire study population was 1.34 (IQR: 0.84-2.29). After a median follow-up time of 60 (range 17-227.5) days, 205 deaths occurred. After fully adjusting for hepatomegaly, albumin, fibrinogen, EBV, ferritin, etiologies, and treatment strategies, the adjusted hazard ratios (HRs) with corresponding confidence intervals (CIs) of mortality for the 2 st tertile and 3 st tertile were 1.2 (0.8-1.7) and 1.6 (1.1-2.2), respectively (P<0.01 for trends). Restricted cubic spline confirmed a linear association between the log2-transformed De Ritis ratio and the risk of mortality. Moreover, this trend persisted in subgroups with MHLH, hyperferrinaemia, sCD25≤20,000 ng/L, patients without EBV infection, and those received treatment. Conclusions. The De Ritis ratio is a strong and independent predictor for overall survival in patients with sHLH. As a readily available biomarker in routine clinical practice, it is used to identify patients with sHLH with inferior overall survival.
format Article
id doaj-art-dd8c7e2b6f7a465faca897fbb537ffa3
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-dd8c7e2b6f7a465faca897fbb537ffa32025-08-20T03:26:05ZengWileyMediators of Inflammation0962-93511466-18612020-01-01202010.1155/2020/57197515719751The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic LymphohistiocytosisGuangli Yin0Changfeng Man1Shengen Liao2Hongxia Qiu3Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, 300 Guangzhou Road, Nanjing 210029, ChinaDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, 300 Guangzhou Road, Nanjing 210029, ChinaDepartment of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, ChinaDepartment of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, 300 Guangzhou Road, Nanjing 210029, ChinaPurpose. Secondary hemophagocytic lymphohistiocytosis (sHLH) accompanied by liver involvement, characterized by hepatomegaly and increased liver enzymes, is usually associated with elevated mortality. However, the magnitude of these associations remains unknown. Our objective was to assess the associations of the aspartate transaminase/alanine transaminase (AST/ALT, De Ritis) ratio with overall survival among adult patients with sHLH. Methods. A retrospective analysis was performed on 289 patients aged 18–86 years with complete serum transaminase data at diagnosis of sHLH. Multivariate Cox regression analyses and restricted cubic splines were conducted to address the association between the De Ritis ratio and the risk of mortality. Results. The median De Ritis ratio for the entire study population was 1.34 (IQR: 0.84-2.29). After a median follow-up time of 60 (range 17-227.5) days, 205 deaths occurred. After fully adjusting for hepatomegaly, albumin, fibrinogen, EBV, ferritin, etiologies, and treatment strategies, the adjusted hazard ratios (HRs) with corresponding confidence intervals (CIs) of mortality for the 2 st tertile and 3 st tertile were 1.2 (0.8-1.7) and 1.6 (1.1-2.2), respectively (P<0.01 for trends). Restricted cubic spline confirmed a linear association between the log2-transformed De Ritis ratio and the risk of mortality. Moreover, this trend persisted in subgroups with MHLH, hyperferrinaemia, sCD25≤20,000 ng/L, patients without EBV infection, and those received treatment. Conclusions. The De Ritis ratio is a strong and independent predictor for overall survival in patients with sHLH. As a readily available biomarker in routine clinical practice, it is used to identify patients with sHLH with inferior overall survival.http://dx.doi.org/10.1155/2020/5719751
spellingShingle Guangli Yin
Changfeng Man
Shengen Liao
Hongxia Qiu
The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis
Mediators of Inflammation
title The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis
title_full The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis
title_fullStr The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis
title_full_unstemmed The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis
title_short The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis
title_sort prognosis role of ast alt de ritis ratio in patients with adult secondary hemophagocytic lymphohistiocytosis
url http://dx.doi.org/10.1155/2020/5719751
work_keys_str_mv AT guangliyin theprognosisroleofastaltderitisratioinpatientswithadultsecondaryhemophagocyticlymphohistiocytosis
AT changfengman theprognosisroleofastaltderitisratioinpatientswithadultsecondaryhemophagocyticlymphohistiocytosis
AT shengenliao theprognosisroleofastaltderitisratioinpatientswithadultsecondaryhemophagocyticlymphohistiocytosis
AT hongxiaqiu theprognosisroleofastaltderitisratioinpatientswithadultsecondaryhemophagocyticlymphohistiocytosis
AT guangliyin prognosisroleofastaltderitisratioinpatientswithadultsecondaryhemophagocyticlymphohistiocytosis
AT changfengman prognosisroleofastaltderitisratioinpatientswithadultsecondaryhemophagocyticlymphohistiocytosis
AT shengenliao prognosisroleofastaltderitisratioinpatientswithadultsecondaryhemophagocyticlymphohistiocytosis
AT hongxiaqiu prognosisroleofastaltderitisratioinpatientswithadultsecondaryhemophagocyticlymphohistiocytosis